Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C1 inhibitor hinge region mutations produce dysfunction by different mechanisms.

A E Davis1, K Aulak, R B Parad

  • 1Division of Nephrology, Children's Hospital Research Foundation, Cincinnati, Ohio.

Nature Genetics
|August 1, 1992
PubMed
Summary

Mutations in the C1 inhibitor protein cause hereditary angioneurotic oedema. Researchers found two distinct mutations leading to dysfunctional C1 inhibitor, affecting its interaction with proteases differently.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK.

HIV medicine·2019
Same author

A Good Book on Massage.

The Hospital·2018
Same author

The efficiency of complement activation in MHC-linked diseases.

Immunology today·2014
Same author

386 computer: a solution to 'computer lag' in medical practice.

Canadian family physician Medecin de famille canadien·2011
Same author

Agenda and infoselect: Personal information managers for physician problem solving.

Canadian family physician Medecin de famille canadien·2011
Same author

Radio-oleic-acid and Radiotriolein Tests in Differential Diagnosis of Steatorrhoea.

British medical journal·2010

Area of Science:

  • Biochemistry
  • Immunology
  • Genetics

Background:

  • Type II hereditary angioneurotic oedema is linked to dysfunctional C1 inhibitor protein.
  • C1 inhibitor is a crucial member of the serine proteinase inhibitor (serpin) superfamily.

Purpose of the Study:

  • To investigate the functional impact of specific mutations in the C1 inhibitor.
  • To elucidate the molecular mechanisms underlying C1 inhibitor dysfunction in hereditary angioneurotic oedema.

Main Methods:

  • Site-directed mutagenesis to create recombinant C1 inhibitor variants (P10 Ala-->Thr and P14 Val-->Glu).
  • Assays to assess complex formation between mutant C1 inhibitors and target proteases (C1s, kallikrein, beta-factor Xlla).
  • Analysis of cleavage products of C1 inhibitor mutants by C1s.

Related Experiment Videos

Main Results:

  • Both P10 Ala-->Thr and P14 Val-->Glu mutants failed to form stable complexes with fluid phase C1s and kallikrein.
  • The P14 Val-->Glu mutant was cleaved by C1s into a 96K form, indicating conversion to a substrate.
  • The P10 Ala-->Thr mutant did not interact with C1s, kallikrein, or beta-factor Xlla-Sepharose, suggesting blocked protease interaction.

Conclusions:

  • The P14 Val-->Glu mutation leads to C1 inhibitor dysfunction by converting it into a substrate for C1s.
  • The P10 Ala-->Thr mutation results in C1 inhibitor dysfunction by preventing its interaction with target proteases.
  • These findings clarify distinct molecular mechanisms of C1 inhibitor dysfunction in hereditary angioneurotic oedema.